$ Value
$34K
Shares
2,505
Price
$14
Filed
Jan 2
Insider
Name
DiRaimondo Thomas
Title
Chief Scientific Officer
CIK
0002005618
Roles
Transaction Details
Transaction Date
2026-01-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
124,425
Footnotes
The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units. | Includes 4,049 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on May 15, 2025. Also, on January 3, 2025, the Reporting Person filed a Form 4 which inadvertently reported an aggregate of 7,781 shares acquired under the Plan. In fact, 5,432 of the shares were already reported as acquired by the Reporting Person under the Plan on a Form 3 filed on January 3, 2024 and 1,406 of the shares were reported as acquired by the Reporting Person under the Plan on a Form 4 filed on September 27, 2024. | Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027. | 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Filing Info
DiRaimondo Thomas's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | JANX | ▼ | $34K |
| 2026-01-02 | JANX | A | $0 |
| 2026-01-02 | JANX | A | $0 |
Other Insiders at JANX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Go William
Chief Medical Officer
|
— | — | 2026-02-02 |